Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Price Passes Above 50-Day Moving Average - Here's What Happened

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) shares crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $7.86 and traded as high as $9.16. Bavarian Nordic A/S shares last traded at $9.16, with a volume of 720 shares trading hands.

Bavarian Nordic A/S Price Performance

The firm's 50-day simple moving average is $7.93 and its 200 day simple moving average is $8.33. The firm has a market capitalization of $2.17 billion, a price-to-earnings ratio of 13.28 and a beta of 1.44.

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported $0.13 earnings per share for the quarter. The company had revenue of $189.89 million for the quarter. Bavarian Nordic A/S had a net margin of 18.33% and a return on equity of 10.65%. As a group, research analysts predict that Bavarian Nordic A/S will post 0.67 earnings per share for the current year.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.